Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Drug Companies to Benefit from R&D Tax Break Reform
January 7, 2008
- TOPICS／NBI Helps Employees Manage Work and Family Life
January 7, 2008
- REGULATORY NEWS IN BRIEF
January 7, 2008
- Patient-Centered Healthcare - 10 Concerns of Patients
January 7, 2008
- 54 New Drugs Approved in 1st Half of FY2007: PMDA
January 7, 2008
- AstraZeneca to Start PI for 20 Products in 2008, as in 2007: CEO D. Brennan
January 7, 2008
- 7 New Products Included in NHI Price List
January 7, 2008
- MEDICAL DEVICE NEWS IN BRIEF
January 7, 2008
- NHI Drug Prices to Receive 5.2% Cut in April 2008
January 7, 2008
- Concurrent Use of Unapproved Drugs with Insurance-Covered Healthcare to Be Allowed
January 7, 2008
- Mean Gap of 6.9% Found between Market Prices and NHI Prices
January 7, 2008
- Banyu Commemorates 1st Anniversary of Preminent Launching
January 7, 2008
- Korosho, MOF Agree on 0.38% Increase in Medical Fees
January 7, 2008
- GENERICS NEWS IN BRIEF
January 7, 2008
- Gov't Decides to Increase Medical Fees 0.38%
January 7, 2008
- Kyowa Pharm. Ind. to Launch 20 New Products Every Year
January 7, 2008
- BUSINESS NEWS IN BRIEF
January 7, 2008
- SSP Revises Business Forecast Upward
January 7, 2008
- NEW PRODUCTS
January 7, 2008
- Taisho to Launch RiUP Plus
January 7, 2008
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…